As depicted in Figure 5 A, the RMBN treatment resulted in a significant decrease in the IL-6 concentration and a decreasing trend in the TNF-α and MCP-1 levels in the LPS/GalN-induced ALF model mice, indicating that the RMBN treatment has the potential to alleviate the increase in the levels of proinflammatory cytokines.
← all excerpts
A Biomimetic Multifunctional Nanoframework for Symptom Relief and Restorative Treatment of Acute Liver Failure.
1
—
—